A phase II trial of conventional radiation therapy (XRT) plus high dose tamoxifen (TAM) for the treatment of supratentorial glioblastoma multiforme (GBM): RTOG protocol BR-0021

被引：0
|
作者：
Robins, H [1 ]
Won, N [1 ]
Seiferheld, W [1 ]
Schultz, C [1 ]
Choucair, A [1 ]
Brachman, D [1 ]
Demas, W [1 ]
Mehra, MP [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [41] Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
    Brown, Paul D.
    Krishnan, Sunil
    Sarkaria, Jann N.
    Wu, Wenting
    Jaeckle, Kurt A.
    Uhm, Joon H.
    Geoffroy, Francois J.
    Arusell, Robert
    Kitange, Gaspar
    Jenkins, Robert B.
    Kugler, John W.
    Morton, Roscoe F.
    Rowland, Kendrith M., Jr.
    Mischel, Paul
    Yong, William H.
    Scheithauer, Bernd W.
    Schiff, David
    Giannini, Caterina
    Buckner, Jan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5603 - 5609
  • [42] A PHASE-II TRIAL OF INTERMITTENT LEUKOCYTE INTERFERON AND HIGH-DOSE CHLORAMBUCIL IN THE TREATMENT OF NON-HODGKINS LYMPHOMA RESISTANT TO CONVENTIONAL THERAPY
    CLARK, RH
    DIMITROV, NV
    AXELSON, JA
    CHARAMELLA, LJ
    STOTT, PB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 75 - 77
  • [43] Preoperative treatment with mFOLFIRINOX plus /- isotoxic high-dose stereotactic body radiation therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): A randomized comparative multicenter phase II trial
    Bouchart, Christelle
    Navez, Julie
    Borbath, Ivan
    Geboes, Karen
    Vandamme, Timon
    Closset, Jean
    Moretti, Luigi
    Demetter, Pieter
    Paesmans, Marianne
    Van Laethem, Jean-Luc
    CANCER RESEARCH, 2024, 84 (02)
  • [44] Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel plus /- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
    Bouchart, Christelle
    Navez, Julie
    Borbath, Ivan
    Geboes, Karen
    Vandamme, Timon
    Closset, Jean
    Moretti, Luigi
    Demetter, Pieter
    Paesmans, Marianne
    Van Laethem, Jean-Luc
    BMC CANCER, 2023, 23 (01)
  • [45] Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: Preliminary results of a phase II trial
    Linares, LA
    Echols, D
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 58 - 62
  • [46] Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
    Minsky, BD
    Neuberg, D
    Kelsen, DP
    Pisansky, TM
    Ginsberg, RJ
    Pajak, T
    Salter, M
    Benson, AB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 517 - 523
  • [47] Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
    Int J Radiat Oncol Biol Phys, 3 (517-523):
  • [48] Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
    Christelle Bouchart
    Julie Navez
    Ivan Borbath
    Karen Geboes
    Timon Vandamme
    Jean Closset
    Luigi Moretti
    Pieter Demetter
    Marianne Paesmans
    Jean-Luc Van Laethem
    BMC Cancer, 23 (1)
  • [49] Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation (XRT) in recurrent squamous cell carcinoma of the head and neck (SCCHN): Long-term follow-up of Radiation Therapy Oncology Group (RTOG) protocol 9911
    Langer, Corey J.
    Harris, Jonathan
    Horwitz, Eric M.
    Kies, Merrill S.
    Curran, Walter J.
    Wong, Stuart J.
    Zhang, Qiang
    Ang, K. Kian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma Study protocol for a randomized controlled phase II trial
    Wen, Yixue
    Zhao, Zhenhuan
    Miao, Jidong
    Yang, Qilin
    Gui, Yan
    Sun, Mingqiang
    Tian, Honggang
    Jia, Qiang
    Liao, Dongbiao
    Yang, Chen
    Du, Xiaobo
    MEDICINE, 2017, 96 (49)
12345